Back to Dashboard
TEVA · Healthcare

TEVA PHARMACEUTICAL INDUSTRIES

USA Healthcare Filing: 2023-12-31
Smart-money confidence · 1 of 3 sources firing
Weak — few signals

No standout activity across the feeds we track.

Hedge funds
54
Congress
0
Insiders
50
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s.  ·  how the score works
Limited info. TEVA PHARMACEUTICAL INDUSTRIES is not currently in our model portfolio, but 9 tracked investors hold it. We're showing what we know from their latest 13F filings.
Market cap
$37.5B
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NYSE
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The company also focuses on the central nervous system…
9
Investors
1
New positions
3
Increasing
4
Decreasing
1
Unchanged
Price History
Loading price data...
Return: High: Low:
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Trust weight: 1.3×
New position
% of portfolio
0.1%
Position change
NEW
0.1% of Greenlight Capital's portfolio
Trust weight: 1.0×
Increased +212%
% of portfolio
0.1%
Position change
+212%
0.1% of Citadel Advisors's portfolio
Trust weight: 1.0×
Increased +282%
% of portfolio
0.0%
Position change
+282%
0.0% of D.E. Shaw & Co's portfolio
Trust weight: 1.0×
Increased +56%
% of portfolio
0.0%
Position change
+56%
0.0% of AQR Capital Management's portfolio
Trust weight: 1.2×
Unchanged
% of portfolio
11.1%
Position change
11.1% of Glenview Capital Mgmt's portfolio
Trust weight: 1.6×
Decreased −65%
% of portfolio
4.3%
Position change
−65%
4.3% of Duquesne Family Office's portfolio
Trust weight: 1.3×
Decreased −13%
% of portfolio
0.1%
Position change
−13%
0.1% of Bridgewater Associates's portfolio
Trust weight: 1.2×
Decreased −23%
% of portfolio
0.1%
Position change
−23%
0.1% of Tudor Investment's portfolio
Trust weight: 1.3×
Decreased −11%
% of portfolio
0.0%
Position change
−11%
0.0% of ARK Invest's portfolio
Portfolio Allocation
How much of each investor's portfolio is allocated to TEVA PHARMACEUTICAL INDUSTRIES
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell TEVA PHARMACEUTICAL INDUSTRIES or any security.

Get the Weekly Update

Every Sunday, we'll send you what Buffett, Dalio, Ackman and 47 other legendary investors are buying — free, straight from their SEC filings.
Free forever · No spam · Unsubscribe anytime